Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SENT-001
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Recipient : Made Scientific
Deal Size : Undisclosed
Deal Type : Partnership
Made Scientific and Sentinel Announce Partnership to Advance ePP Encapsulated Cell Therapy
Details : Made Scientific is partnering with Sentinel BioTherapeutics to manufacture SENT-001, an allogeneic encapsulated cell therapy delivering IL-2 for solid tumor immunotherapy.
Product Name : SENT-001
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
July 15, 2025
Lead Product(s) : SENT-001
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Recipient : Made Scientific
Deal Size : Undisclosed
Deal Type : Partnership